Epstein-Barr virus is linked to multiple diseases, and there is no approved vaccine. Hong et al. characterize antibodies targeting different components of the gHgL-gp42 complex, demonstrating in vitro synergistic neutralization and potent in vivo protection in a triple-antibody format, providing insights for the rational design of therapeutics or vaccines.
All Keywords
【저자키워드】 Neutralizing antibodies, antibody cocktail, Epstein-Barr virus, cryo-EM, gHgL-gp42 complex,
【저자키워드】 Neutralizing antibodies, antibody cocktail, Epstein-Barr virus, cryo-EM, gHgL-gp42 complex,